These findings revealed that high ACOT2 expression was related to the deterioration of OS in patients with AML, which is mainly related to abnormal lipid metabolism, suggesting that ACOT2 may be a potential target for the treatment of AML. The gene discussed is ACOT2; the disease is acute myeloid leukemia.